Sara Mumford, MBA, CIP Associate Director Institutional Review Board
This is a REd Asynchronous (online/self-paced) class.
Information and materials to prepare investigators and research personnel to initiate,
manage and oversee a drug or device trial at the University will be presented. The
Food and Drug Administration (FDA) Investigational New Drug (IND) and Investigational
Device Exemption (IDE) requirements will be described. Topics such as additional investigator
responsibilities, the IRB submission and approval process including pre-approval audit,
and methods of continued study oversight will be discussed.
REd Asynchronous classes feature lessons and exercises designed to build competency and increase efficiency.
Modules are accessible 24/7 and are all self-paced. All members of the University
research community are invited to complete any online classes of interest.